Ether Doai Patents (Class 514/715)
-
Patent number: 8062629Abstract: Provided is a hair cosmetic composition which comprises the following components (A) to (D): (A): an organic acid, (B): an organic solvent selected from aromatic alcohols, polyols and carbonates, (C): a cationic surfactant, and (D): a higher alcohol, and water and has a pH ranging from 2 to 6. The hair cosmetic composition has excellent effects for repairing or preventing hair damage caused by coloring, permanent waving or blow drying and features good feeling upon use and luster improving effect.Type: GrantFiled: February 19, 2003Date of Patent: November 22, 2011Assignee: Kao CorporationInventors: Hiroyuki Terazaki, Masako Ueno
-
Publication number: 20110281945Abstract: To provide a drug, quasi-drug, food or drink that can act as a gastric acid secretion suppressant or a potassium channel inhibitor by including a composition that can be safely used and can be inexpensively produced. Each of these products contains one or more cooling sensation compositions that are compounds providing cooling sensation in an amount sufficient for exhibiting the efficacy thereof in a living body to which the product is administered.Type: ApplicationFiled: January 26, 2010Publication date: November 17, 2011Inventors: Yuichi Suzuki, Kenya Ishida, Mitsuhiko Fujiwhara
-
Publication number: 20110105507Abstract: Provided are new functionalized surfactants and methods of their preparation and use. The surfactants are compounds of formula I: wherein R1, R2, and R3 are as defined herein.Type: ApplicationFiled: October 21, 2010Publication date: May 5, 2011Inventors: Matthias S. Ober, Edward D. Daugs, Wanglin Yu, Cynthia L. Rand
-
Patent number: 7923473Abstract: Pharmaceutical compositions comprising at least one compound of the formulas (Ia) or (Ib) and a pharmaceutically acceptable carrier wherein the symbols have the following meaning —X— is e.g. and Y being e.g. or the pharmaceutically acceptable salts can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or L-selectin binding.Type: GrantFiled: September 20, 2006Date of Patent: April 12, 2011Assignee: Revotar Biopharmaceuticals AGInventors: Ewald M. Aydt, Remo Kranich, Anke S. Busemann
-
Patent number: 7919532Abstract: Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning —X— is e.g. and Y being e.g. or the pharmaceutically acceptable salts, esters or amides and prodrugs can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or L-selectin binding.Type: GrantFiled: September 20, 2006Date of Patent: April 5, 2011Assignee: Revotar Biopharmaceuticals AGInventors: Ewald M. Aydt, Remo Kranich
-
Publication number: 20110071225Abstract: A method for obtaining a sequoyitol-containing extract from a plant of genus Nephrolepis, comprising extracting with a solvent, recovering the solvent to give an extractum, subjecting the extractum to two-phase extraction and column chromatography, collecting the fractions containing sequoyitol, concentrating, filtration and drying. The main active ingredient of the extract obtained is sequoyitol, which can be used for treating diabetes and its complications.Type: ApplicationFiled: May 19, 2008Publication date: March 24, 2011Applicant: GUANGZHOU WELMAN NEW DRUG R&D CO., LTD.Inventors: Tianyu Sun, Yanli Wang, Yinyin Wang, You Lu, Ting Wang
-
Patent number: 7906557Abstract: The present invention provides an oral preventive or therapeutic agent for skin damage, containing diacylglyceryl ether as an active ingredient represented by the formula (I): wherein R1 denotes C12-24 aliphatic hydrocarbon group having a degree of unsaturation of between 0 and 2; R2 denotes C12-24 acyl group having a degree of unsaturation of between 0 and 6; and R3 denotes C12-24 acyl group having a degree of unsaturation of between 0 and 6.Type: GrantFiled: June 17, 2003Date of Patent: March 15, 2011Assignee: Maruha Nichiro Seafoods, Inc.Inventors: Masazumi Nishikawa, Itsuki Murota, Tadakazu Tamai, Kazuyoshi Yoshikai
-
Patent number: 7906128Abstract: The present invention provides an effective method and composition for the prevention, amelioration or control of external parasites on a human or animal via the administration of a prophylactically, therapeutically or pharmaceutically effective amount of a neuronal sodium channel antagonist to a human or animal in need thereof.Type: GrantFiled: October 14, 2003Date of Patent: March 15, 2011Assignee: Wyeth LLCInventors: Kathleen Heaney, Susan J. Dunney, Douglas Rugg
-
Patent number: 7897647Abstract: Activated polymeric bicine derivatives such as as well as conjugates made therewith are disclosed. Methods of making and using the bicine derivatives are also disclosed.Type: GrantFiled: August 9, 2006Date of Patent: March 1, 2011Assignee: Enzon Pharmaceuticals, Inc.Inventors: Hong Zhao, Richard B. Greenwald, Annapurna Pendri
-
Patent number: 7858611Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The invention includes compositions and methods based on modulation angiotensin activity to stimulate or activate the formation of new nerve cells.Type: GrantFiled: May 9, 2007Date of Patent: December 28, 2010Assignee: BrainCells Inc.Inventors: Carrolee Barlow, Todd A. Carter, Kai Treuner, Kym I. Lorrain
-
Patent number: 7816409Abstract: The present invention has as objective the stabilization of a fluoroether compound against degradation by acid substances. The stabilizers proposed are selected among propylene glycol, polyethylene glycol, hexylene glycol, 1,3-butylene glycol and a saturated cyclic alcohol preferably menthol and are used for preparing stable pharmaceutical compositions of a fluoroether compound. Method for stabilizing a fluoroether compound and use of stabilizers agents for precluding the degradation of a fluoroether are also described.Type: GrantFiled: August 20, 2004Date of Patent: October 19, 2010Assignee: Cristalia Productos Quimicos Farmaceuticos LTDAInventors: Ogari Pacheco, Elisa Russo, Valter Russo, José Antônio Martins, Maria Alice Bockelmann, Simone Rosatto
-
Publication number: 20100216876Abstract: An antidiarrhetic composition is provided which is efficacious against diarrhea, in particular, the predominant secretory diarrhea; an antidiarrhetic medicinal composition containing the same is also provided; a food containing the antidiarrhetic composition is also provided; and a method of preventing diarrhea using the same is also disclosed. The composition for relieving diarrhea is a cool composition capable of acting on the digestive tract in the recipient's body and inhibiting the secretion of the intestinal Cl?. In other words, a composition containing one or more kinds of cool act compounds. It may be provided by adding to medicines, foods or drinks.Type: ApplicationFiled: October 2, 2008Publication date: August 26, 2010Inventors: Yuichi Suzuki, Kenya Ishida
-
Publication number: 20100210733Abstract: The present invention provides a composition for inhibiting osteoclastogenesis and a pharmaceutical composition for preventing or treating a bone metabolism disorder, which comprise D-pinitol as an active ingredient. The present compositions have an inhibitory activity on the differentiation of osteoclast and are useful in the prevention or treatment of a bone metabolism disorder resulting from overactivity or hyper-proliferation of osteoclasts.Type: ApplicationFiled: September 3, 2008Publication date: August 19, 2010Applicant: Solgent Co.Inventors: Jaerang Rho, Hyeon-Koon Myeong
-
Publication number: 20100184866Abstract: Compounds are provided herein which are coordination complexes of the formula, AxByCit2Fz.mH2O, wherein A is a cation selected from certain IA or IIA metal ions in the Periodic Table; B is a cation selected from certain IIA metal ions and certain divalent d-block transition metal ions; A and B are different; “Cit” is tribasic citric acid anion; the stoichiometric ratio of x to y is equal or higher than 1.0 but lower than 8.0; m is 0-12; and z is selected such that electroneutrality is preserved. Compounds provided herein are useful to treat dietary deficiencies, osteoporosis, osteopenia, bone loss, and risk of bone loss, as well as other medical conditions involving the need for administration of the various ions. In addition, the compounds can be used as fluoride sources for dental use and to fluoridate water systems.Type: ApplicationFiled: January 4, 2010Publication date: July 22, 2010Applicant: Mission Pharmacal CompanyInventors: Mary Ann Walter, Jian Gao, Neill Bailey Walsdorf
-
Publication number: 20100160243Abstract: Compounds and methods for enhancing erythropoiesis. The compound contains a chemical structure of the formula (I) indicated below, in which R is a glucosyl group. In addition to having an erythropoiesis effect, the compound of the formula (1) is effective in enhancing erythropoietin formation, and increasing kidney function and expression of hepatocyte growth factor. The method includes the step of administering an effective amount of the compound of the formula (I) to a subject in need thereof and thereby results in an enhancement of erythropoiesis.Type: ApplicationFiled: December 24, 2008Publication date: June 24, 2010Applicant: National Yang-Ming UniversityInventor: Rong-Tsun WU
-
Publication number: 20100144890Abstract: Use of a mixture comprising at least one non-aromatic surfactant having a plurality of ether and/or ester groups and at least one carrier agent for the preparation of a formulation for the treatment of adipose tissue disease and/or condition with improved bioavailability and lipolysis behaviour.Type: ApplicationFiled: January 14, 2008Publication date: June 10, 2010Inventors: Peter Boderke, Bernhard Hauptmeier, Edgar Mentrup, Holger Kohler, Rainer Pooth
-
Publication number: 20100105631Abstract: Inositol derivatives are described that are represented by the structural formula I wherein X is a radical of scyllo-inositol wherein one or more of R1, R2, R3, R4, R5, and R6 are independently alkyl, alkenyl, alkynyl, alkylene, alkenylene, alkoxy, alkenyloxy, cycloalkyl, cycloalkenyl, cycloalkoxy, aryl, aryloxy, arylalkoxy, aroyl, heteroaryl, heterocyclic, acyl, acyloxy, sulfoxide, sulfate, sulfonyl, sulfenyl, sulfonate, sulfinyl, amino, imino, azido, thiol, thioalkyl, thioalkoxy, thioaryl, nitro, cyano, halo, seleno, silyl, silyloxy, silylthio, carboxyl, carbonyl, carbamoyl, or carboxamide and the other of R1, R2, R3, R4, R5, or R6 are hydroxyl, or pharmaceutically acceptable salts thereof. The compounds, compositions comprising same and methods using same are described for use in the prevention and/or treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, desposition, accumulation or persistence.Type: ApplicationFiled: November 11, 2009Publication date: April 29, 2010Inventors: Antonio Curz, Linda Kurdydyk
-
Patent number: 7704519Abstract: A composition for application to exterior surfaces, such as trees, so as to prevent animal damage to the exterior surface, has asphalt and denatonium benzoate mixed together. The denatonium benzoate is 1% to 50% by weight of the total composition. The asphalt is between 50% and 60% of the total composition. Naphtha and dimethyl ether are further components of the total composition. The composition is sprayable onto the exterior surface.Type: GrantFiled: October 30, 2006Date of Patent: April 27, 2010Inventor: John Baldwin
-
Publication number: 20100093871Abstract: Disclosed is an agent for prevention or treatment of iron overload disorders, comprising 22?-methoxyolean-12-ene-3?,24(4?)-diol or a pharmacologically acceptable salt thereof.Type: ApplicationFiled: March 19, 2008Publication date: April 15, 2010Applicant: MEIJI SEIKA KAISHA, LTD.Inventors: Hideaki Kagehara, Shoji Nishiyama
-
Patent number: 7695730Abstract: This invention relates to substantially anhydrous warming, non-toxic and nonirritating lubricating compositions containing polyols and preferably an insulating agent. The invention also relates to methods of using such compositions for lubrication, administration of active ingredients and for preventing or treating dysmenorrhea.Type: GrantFiled: May 17, 2004Date of Patent: April 13, 2010Assignee: McNeil-PPC, Inc.Inventors: Nawaz Ahmad, Christopher Scott Lamb, Emilia Casilio Lonardo, Michael E. Joyce, Kalpana J. Patel, Pavan Kumar Heda
-
Publication number: 20100076080Abstract: The present invention provides synthetic routes for preparing various isomers of cyclohexane-based coolants, such as menthyl esters and menthanecarboxamide derivatives, in particular those substituted at the amide nitrogen, for example with an aromatic ring or aryl moiety. Such structures have high cooling potency and long lasting sensory effect, which make them useful in a wide variety of consumer products. One synthetic route involves a copper catalyzed coupling of a primary menthanecarboxamide with an aryl halide, such reaction working best in the presence of potassium phosphate and water. Using this synthetic route, specific isomers can be prepared including the menthanecarboxamide isomer having the same configuration as l-menthol and new isomers such as a neoisomer having opposite stereochemistry at the carboxamide (C-1) position. The neoisomer unexpectedly has potent and long lasting cooling effect.Type: ApplicationFiled: August 14, 2009Publication date: March 25, 2010Inventors: Kenneth Edward Yelm, Gregory Mark Bunke, John Christian Haught
-
Patent number: 7670615Abstract: An alcoholic foam composition, which can be dispensed as a foam via a pump-foam system contains a) at least 52 to ?99 wt % of an alcohol or mixture of alcohols, b) a surfactant or a surfactant mixture, c) at least one polyalkylene glycol, d) optionally, at least one foam stabilizer, e) optionally, at least one member selected from the group consisting of cosmetic auxiliaries, adjuvants, active ingredients, and mixtures thereof, and f) optionally water. The surface tension of component b) lies in the range of ±15 dyn/cm of the surface tension of component a) or corresponds to the surface tension of component a), and the sum of components a) to f) is 100 wt % relative to the total quantity of the foam composition.Type: GrantFiled: December 21, 2005Date of Patent: March 2, 2010Assignee: Stockhausen GmbHInventors: Marcel Veeger, Markus Himming
-
Patent number: 7658941Abstract: This invention relates to substantially anhydrous warming, non-toxic and nonirritating lubricating compositions containing polyhydric alcohols and an insulating agent as well as gel and jelly compositions related thereto. The invention also relates to methods of using such compositions for lubrication, administration of active ingredients and for preventing or treating dysmenorrhea.Type: GrantFiled: May 17, 2004Date of Patent: February 9, 2010Assignee: Johnson & Johnson Consumer Companies, Inc.Inventors: Nawaz Ahmad, Christopher Scott Lamb, Emilia Casilio Lonardo, Michael E. Joyce, Kalpana J. Patel, Pavan Kumar Heda
-
Publication number: 20090306196Abstract: The present invention relates to a delivery system based on a film of an imine forming liquid crystalline phase, mixed with at least with one biologically active substance, to which a constant or variable electric field can be applied. The delivery system can be used as a delivery system for biologically active substances such as flavors, fragrances, bactericides, fungicides, insecticides, insect attractants or repellents, agrochemicals or pharmaceuticals.Type: ApplicationFiled: March 19, 2007Publication date: December 10, 2009Applicants: FIRMENICH SA, UNIVERSITE LOUIS PASTEUR, Centre National De La Recherche ScientifiqueInventors: Jean-Marie Lehn, Nicolas Giuseppone, Andreas Herrmann
-
Publication number: 20090298936Abstract: The present invention relates to a method for energizing a human being and to administering an energizing (personal care) composition to human beings wherein said composition contains one or more fragrance materials of group (a) of the present invention.Type: ApplicationFiled: May 29, 2008Publication date: December 3, 2009Applicant: SYMRISE GmbH & Co. KGInventors: James G. Clothier, JR., Keith McDermott, Patrice Bellon
-
Publication number: 20090227685Abstract: The present invention is directed to novel compounds of the general formula wherein R is hydrogen, a straight, branched or cyclic hydrocarbon moiety consisting of less than 10, most preferably less than 4 carbon atoms and containing single and/or double bonds, an acetyl group and substituted acetyl groups including cyclic groups, such as cyclopropyl acyl group, alkoxy ether groups and alkyl substituted alkoxy ether moieties such as, but not limited to, CH2—O—CH2—R5 wherein R5 is a C1-C4 alkyl group as well as double bond containing alkyl groups; R1 is selected from the group consisting of hydrogen or a C1-C4 alkyl group and R2 and R3 is independently equal to methyl; and wherein one of the dashed lines between the 5 and 10 position, the 4 and 5 position and the 5 and 6 position represents a second C—C bond in a C?C double bond.Type: ApplicationFiled: April 11, 2008Publication date: September 10, 2009Inventors: Anubhav P.S. Narula, Edward Mark Arruda, Paul J. Pieschl
-
Publication number: 20090196939Abstract: A method for antimicrobial treatment (e.g. antimicrobial treatment of food packaging and equipment) comprising applying to microbes a composition containing a diluting solvent (e.g., water), an antimicrobially-active solvent having a density different from the density of the diluting solvent, and an optional cosolvent, surfactant, or additional antimicrobial agent, wherein the amount of antimicrobially-active solvent or additional antimicrobial agent is sufficiently high and the amount of cosolvent or surfactant is sufficiently low so that the composition will provide greater than a 1-log order reduction in the population of bacteria or spores of Bacillus cereus within 10 seconds at 60° C. Preferred methods of the invention employ compositions containing an additional antimicrobial agent such as peroxyacetic acid. Compositions for use in the method can be prepared as concentrates, and used full strength or in diluted form.Type: ApplicationFiled: February 9, 2009Publication date: August 6, 2009Applicant: ECOLAB INC.Inventors: Robert D.P. Hei, Guang-jong J. Wei, David A. Halsrud, Kim R. Smith, Teresa C. Podtburg
-
Publication number: 20090105260Abstract: An IR spectroscopic technique provides methods for measuring the irritation potential of a formulation and to assess the ability of molecules to enhance the permeability of substances into and through skin using samples comprising stratum corneum. Molecules are screened for their performance as chemical penetration enhancers using a unique in silico procedure that may be applied iteratively in an attempt to generate molecules showing successively higher performance. Both the irritation potential and the ability of the molecule to enhance penetration are considered in the in silico approach. The invention provides specific molecules that may be used in topical or transdermal formulations to improve the delivery of actives. The structures of compounds of the invention include: Formulas (I), (II), (III), (IV), (V), (IV) and analogs thereof.Type: ApplicationFiled: January 17, 2006Publication date: April 23, 2009Inventors: Samir Mitragotri, Pankaj Karande, Amit K. Jain
-
Patent number: 7504091Abstract: antiperspirant compositions comprise an antiperspirant active and a carrier oil in which the carrier oil comprises an aromatic ester oil obeying the general formula: R1—CO2—X—Y—R2 in which R1 and R2 each represent a phenyl group, X represents an alkylene group containing from 2 to 4 carbons including at least one pendant alkyl group and Y represents a bond, or an ether or ester linkage.Type: GrantFiled: April 13, 2005Date of Patent: March 17, 2009Assignee: Unilever Home & Personal Care USA, division of Conopco, Inc.Inventor: Kevin Ronald Franklin
-
Patent number: 7485666Abstract: The invention provides compositions and methods for increasing cell growth, stimulating cell turnover and promoting the secretion of mucus within the reproductive tract of a female mammal.Type: GrantFiled: June 17, 2004Date of Patent: February 3, 2009Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Julie M. Villanueva, Sohail Malik
-
Patent number: 7473711Abstract: The present invention is directed to a class of 4-cyano-phenoxy derivatives of formula I and to their use as androgen receptor modulators. Other aspects of the invention are directed to the use of these compounds to decrease excess sebum secretions and to stimulate hair growth.Type: GrantFiled: April 15, 2005Date of Patent: January 6, 2009Assignee: Pfizer Inc.Inventors: Lain-Yen Hu, Huangshu Lei, Daniel Y. Du, Bruce A. Lefker
-
Publication number: 20080280972Abstract: A proliferation of cells can be reduced by contacting the cells with a compound having formula (I) where R and R? are each alkyl groups, R? is hydrogen or an alkyl group and X3, X4 and X5 are each independently selected from the group consisting of hydrogen, benzyl, t-butyldimethylsiloxy radical and triphenylmethyl. Accordingly, compounds of formula (I) can be used for treatment of tumors including melanoma. Also a secretion of a matrix metalloproteinase (MMP) enzyme by cells can be reduced by contacting the cells with the compound having formula (I). Accordingly, compounds of formula (I) can be used for treatment physiological conditions associated with an elevated MMP level, such as tumors.Type: ApplicationFiled: April 18, 2008Publication date: November 13, 2008Inventors: Raymond Dwek, Wanda Buzgariu, Anca Hirtopeanu, Robert Moriarty, Gabriela Negroiu, Norica Nichita, Livia Zdrentu, Nicole Zitzmann
-
Publication number: 20080206365Abstract: Provided are a certain compounds and compositions useful for inhibiting or activating the production of various types of cytokines. Also provided are certain compounds and compositions for preventing or treating various diseases attributable to abnormal cytokine production or compromised immunity.Type: ApplicationFiled: February 28, 2007Publication date: August 28, 2008Inventors: Yoshihisa Tachibana, Shoichiro Kurata, Yoshiteru Oshima, Kazunori Ueda, Haruhisa Kikuchil
-
Patent number: 7413738Abstract: Activated polymeric bicine derivatives such as, as well as conjugates made therewith are disclosed. Methods of making and using the bicine derivatives are also disclosed.Type: GrantFiled: December 14, 2004Date of Patent: August 19, 2008Assignee: Enzon Pharmaceuticals, Inc.Inventors: Hong Zhao, Susan Adler, legal representative, Richard B. Greenwald
-
Patent number: 7414079Abstract: Acyclic compounds containing an ether functionality external to the ring can be used as rhinologically active substances. In the regions of the mouth, the throat and the airways they produce a refreshing and clearing feeling.Type: GrantFiled: July 24, 2003Date of Patent: August 19, 2008Assignee: Symrise GmbH & Co. KGInventors: Horst Surburg, Arnold Machinek, Hubert Loges
-
Publication number: 20080171794Abstract: The present invention relates to a humectant composition containing, as component (A), at least one member selected from a menthol derivative represented by the following formula (1) and p-menthane-3,8-diol: in which R is an alkylene group having 2 to 5 carbon atoms which may be substituted with at least one member selected from the group consisting of a methyl group and a hydroxyl group, and n is an integer of 1 to 3. The humectant composition of the present invention provides an excellent moisture-retention effect.Type: ApplicationFiled: January 16, 2008Publication date: July 17, 2008Applicant: TAKASAGO INTERNATIONAL CORPORATIONInventors: Tetsuya Yamamoto, Kenya Ishida
-
Patent number: 7365097Abstract: Disclosed herein is the cosmetic use, as a desquamating agent, of at least one (dihydro)jasmonic acid derivative of a given formula. Further disclosed herein is a cosmetic method for smoothing the visible and/or tactile irregularities of the skin surface, for example, for smoothing wrinkles and fine lines and/or skin spots and/or smoothing the skin, comprising topically applying, to the skin, a composition comprising, in a physiologically acceptable medium, at least one (dihydro)jasmonic acid derivative and glycerine. Other embodiments disclosed herein are novel (dihydro)jasmonic acid derivatives.Type: GrantFiled: July 27, 2004Date of Patent: April 29, 2008Assignee: L'Oreal, S.A.Inventors: Michel Neuwels, Maria Dalko
-
Publication number: 20080031961Abstract: The present invention relates to benefit agent containing delivery particles, compositions comprising said particles, and processes for making and using the aforementioned particles and compositions. When employed in compositions, for example, personal care, cleaning or fabric care compositions, such particles increase the efficiency of benefit agent delivery, there by allowing reduced amounts of benefit agents to be employed. In addition to allowing the amount of benefit agent to be reduced, such particles allow a broad range of benefit agents to be employed.Type: ApplicationFiled: August 1, 2007Publication date: February 7, 2008Inventors: Philip Andrew Cunningham, Jiten Odhavji Dihora, Ziayou Liu, Peggy Dorothy Sands, Sandra Jacqueline Guinebretiere
-
Patent number: 7282523Abstract: The invention provides methods for treating beta-Amyloid protein-induced disease, pharmaceutical compositions and compounds useful for the same, and the use of these compounds for the manufacture of a medicament for treating the same. More particularly, the invention relates to the use of natural product compounds isolated from turmeric, gingko biloba, and ginger, and synthetic chemical analogues thereof, for the treatment of a beta-Amyloid protein-induced disease.Type: GrantFiled: March 18, 2005Date of Patent: October 16, 2007Inventor: Darrick S. H. L. Kim
-
Patent number: 7135600Abstract: The present invention relates to novel compounds of Formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.Type: GrantFiled: February 11, 2002Date of Patent: November 14, 2006Assignee: Glaxo Group LimitedInventors: Keith Biggadike, Diane Mary Coe, Stephen Barry Guntrip, Brian Edgar Looker, Panayiotis Alexandrou Procopiou
-
Patent number: 7122189Abstract: Activated polymeric bicine derivatives such as as well as conjugates made therewith are disclosed. Methods of making and using the bicine derivatives are also disclosed.Type: GrantFiled: August 13, 2002Date of Patent: October 17, 2006Assignee: Enzon, Inc.Inventors: Hong Zhao, Richard B. Greenwald, Annapurna Pendri
-
Patent number: 7109246Abstract: A formulation, for example an oil-in-water emulsion, comprising an amphoteric surfactant, alkoxylated cetyl alcohol and a polar drug. The drug may be sodium cromoglycate or nedocromil sodium. The formulation may be useful in the treatment of skin disease such as atopic dermatitis.Type: GrantFiled: May 20, 1999Date of Patent: September 19, 2006Assignee: Hewlett Healthcare LtdInventor: Brian Hawtin
-
Patent number: 7109245Abstract: Methods and compounds for reversing pathological vasodilation of blood vessels, for example vasodilation caused by activation of CB1-like receptors, by administering to a subject a therapeutically effective amount of a compound sufficient to induce vasoconstriction, the compound comprising: wherein dashed lines independently represent either a single or a double bond, R1 is a lower alkyl, R2 is a lower alkyl, R3 is a lower alkyl or halogen, R4 is a lower alkyl or hydrogen, R5 is a lower alkyl or hydrogen, R6 is a hydrogen, lower alkyl or halogen, and R7 is a hydrogen, lower alkyl or halogen. The vasoconstrictor can be used for a variety of purposes, including hemostasis or the treatment of shock, for example vasodilatory shock syndromes such as septic shock.Type: GrantFiled: August 14, 2002Date of Patent: September 19, 2006Assignees: The United States of America as represented by the Secretary of the Department of Health and Human Services, Organix Inc.Inventors: George Kunos, Raj K. Razdan
-
Patent number: 7087229Abstract: Activated polymeric bicine derivatives such as, as well as conjugates made therewith are disclosed. Methods of making and using the bicine derivatives are also disclosed.Type: GrantFiled: May 30, 2003Date of Patent: August 8, 2006Assignee: Enzon Pharmaceuticals, Inc.Inventors: Hong Zhao, Richard B. Greenwald
-
Patent number: 7056862Abstract: The invention provides an agricultural chemical enhancer and an agricultural chemical composition which are safely used for crops without any phytotoxicity, have a potency enhancing action on various agricultural chemicals and promote the growth of a plant body to be intended to be grown. The invention relates to an agricultural chemical enhancer comprising at least one type selected from a specific alcohol compound, an ether compound and an ester compound.Type: GrantFiled: December 19, 2001Date of Patent: June 6, 2006Assignee: Kao CorporationInventors: Toshio Hayashi, Tadayuki Suzuki, Kazuhiko Kurita
-
Patent number: 6903114Abstract: Compounds of formula (I?), wherein A, R1 to R3 and t are as defined in the disclosure, exhibit COMT enzyme inhibiting activity so that they are useful as COMT inhibitors.Type: GrantFiled: September 14, 2001Date of Patent: June 7, 2005Assignee: Orion CorporationInventors: Reijo Bäckström, Jarmo Pystynen, Timo Lotta, Martti Ovaska, Jyrki Taskinen
-
Patent number: 6849276Abstract: The invention concerns a phytosanitary fungicide, bactericidal or bacteriostatic composition comprising at least a mineral salt, a copper oxide or hydroxide suspended in an aqueous emulsion of at least a terpene derivative.Type: GrantFiled: August 24, 1999Date of Patent: February 1, 2005Assignee: Action PinInventors: Ghislain Dufau, Michel Barsacq, Gérard Molla
-
Patent number: 6831105Abstract: The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.Type: GrantFiled: November 26, 2002Date of Patent: December 14, 2004Assignee: Esperion Therapeutics, Inc.Inventor: Jean-Louis Henri Dasseux
-
Patent number: 6773727Abstract: Low concentrations of gossypol and related phyllophage toxins from cotton improve the effectiveness of insecticidal agents against social insects, including cockroaches, and particularly termites and ants. Levels of gossypol and other cotton phyllophage toxins which are sufficiently low as to be non-biocidal to social insects alone, will significantly increase the control efficacy of other insecticidal agents. Consequently, use of these low levels of these cotton phyllophage toxins allows the levels of insecticidal agents necessary for effectively controlling the insects to be significantly reduced relative to applications without cotton phyllophage toxins. Furthermore, insecticidal agents which are normally ineffective for control of social insects when used alone, may be effective when used in conjunction with the cotton phyllophage toxins.Type: GrantFiled: August 13, 2001Date of Patent: August 10, 2004Assignee: The United States of America as represented by the Secretary of AgricultureInventors: Maria G. Rojas, Juan A. Morales-Ramos, Peter J. Wan
-
Patent number: 6770636Abstract: Compounds of formula 1, wherein: R1 is hydrogen, hydroxy, CF3, NO2, CN, halogen, C1-C8-alkyl, or C1-C8-alkoxy; R2, R3, and R4 independently of one another are hydrogen, C1-C8-alkyl, hydroxy, NO2, CN, C1-C8-alkoxyl, CF3, or halogen; R5 and R6 independently of one another are hydrogen or a group consisting of C1-C8-alkyl, C2-C8-alkenyl, C3-C8-alkynyl, C3-C8-cycloalkyl, C3-C8-cycloalkyl-C1-C6-alkylene, C5-C8-cycloalkenyl, C5-C8-cycloalkenyl-C1-C6-alkylene, C6-C10-aryl, and C6-C10-aryl-C1-C6-alkylene, each optionally substituted by a group consisting of C1-C6-alkyl, C2-C6-alkenyl, halogen, C1-C6-alkyloxy, —NH2, —NH(C1-C4-alkyl), —N(C1-C4-alkyl)2, hydroxy, ═O, —COOH, —CO—OC1-C4-alkyl, —CONH2, —CONH(C1-C4-alkyl), —CON(C1-C4-alkyl)2, and CF3, or R5 and R6 together with the nitrogen atom are a saturated or unsaturated 5-, 6-, 7-, or 8-membered heterocyclic group optionally containing one or two further heteroatoms consisting of sulfur, oType: GrantFiled: July 24, 2001Date of Patent: August 3, 2004Assignee: Boehringer Ingelheim Pharma KGInventors: Klaus Fuchs, Werner Stransky, Matthias Grauert, Adrian Carter, Wolfram Gaida, Thomas Weiser, Helmut Ensinger